PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2061521
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2061521
According to Mordor Intelligence, the medical tourism market size was valued at USD 93.72 billion in 2025 and is estimated to grow from USD 110.97 billion in 2026 to reach USD 258.32 billion by 2031, at a CAGR of 18.41% during the forecast period (2026-2031).

This report is Segmented by Treatment Type (Dental, Cardiovascular, and More), Service Provider (Public Hospitals, and More), Type (Inbound, Outbound, and Domestic), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). Market Forecasts are Provided in Terms of Value (USD).
U.S. per-capita health spending reached USD 12,555 in 2022, nearly twice Canada's USD 6,207, a gap that has not narrowed because administrative overhead and pharmaceutical pricing in North America remain structurally higher. Rising deductibles and co-pays are prompting insured and self-pay patients to consider bundled packages overseas, where a bariatric procedure in Mexico costs USD 4,000-8,000, compared to USD 15,000-25,000 in the United States, resulting in a 60-70% savings after accounting for airfare. Dental crowns exhibit parallel trends, underscoring the high volume of dental tourists traveling to Mexico, Turkey, and Costa Rica. Because this pressure is systemic rather than cyclical, outbound patient volumes from high-income countries are unlikely to recede during the forecast period, reinforcing medical tourism market growth..
The number of Joint Commission International (JCI)-accredited facilities in the Asia-Pacific and Middle East regions has doubled since 2020, indicating the widespread adoption of universal infection-control and patient-safety protocols. Hospitals that secure early accreditation, such as Bumrungrad International, which treats 600,000 patients from 190 countries annually, leverage that badge to command premium pricing and partner with global insurers. Cleveland Clinic Abu Dhabi and Riyadh's King Salman Medical City are following a similar approach, positioning Gulf Cooperation Council hubs to attract oncology and cardiac cases from Europe and Africa, further strengthening the medical tourism market.
A 2024 survey showed 62% of U.S. orthopedic surgeons decline follow-up for procedures done abroad, citing implant quality and liability concerns. Destination hospitals are mitigating this via 90-day virtual follow-ups bundled in their packages; Apollo and Fortis embed video consults and remote monitoring devices to bridge the gap. Yet insurance exclusions for complications remain common, deterring older or comorbid patients and capping the upper end of the medical tourism market.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.